Stock Scorecard
Stock Summary for Core Laboratories Inc (CLB) - $17.30 as of 4/30/2026 3:21:44 PM EST
Total Score
11 out of 30
Safety Score
22 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CLB
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CLB
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CLB
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CLB
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CLB (22 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for CLB
Financial Details for CLB
Company Overview |
|
|---|---|
| Ticker | CLB |
| Company Name | Core Laboratories Inc |
| Country | N/A |
| Description | Core Laboratories NV (CLB) is a leading provider of advanced reservoir optimization services and products for the oil and gas industry, focused on enhancing reservoir characterization, management, and production efficiency. Leveraging cutting-edge technologies and proprietary analytics, Core Labs drives innovation while prioritizing sustainability in its operations. With a strong global presence, the company is well-positioned to seize emerging growth opportunities and effectively navigate the challenges of the dynamic energy sector. |
| Sector Name | ENERGY |
| Industry Name | OIL & GAS EQUIPMENT & SERVICES |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 4/29/2026 |
Stock Price History |
|
| Last Day Price | 17.30 |
| Price 4 Years Ago | 20.12 |
| Last Day Price Updated | 4/30/2026 3:21:44 PM EST |
| Last Day Volume | 512,361 |
| Average Daily Volume | 378,682 |
| 52-Week High | 20.35 |
| 52-Week Low | 9.71 |
| Last Price to 52 Week Low | 78.17% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 27.01 |
| Sector PE | 27.62 |
| 5-Year Average PE | 19.41 |
| Free Cash Flow Ratio | 34.60 |
| Industry Free Cash Flow Ratio | 26.95 |
| Sector Free Cash Flow Ratio | 107.13 |
| Current Ratio Most Recent Quarter | 2.05 |
| Total Cash Per Share | 0.50 |
| Book Value Per Share Most Recent Quarter | 5.77 |
| Price to Book Ratio | 2.99 |
| Industry Price to Book Ratio | 2.92 |
| Sector Price to Book Ratio | 88.16 |
| Price to Sales Ratio Twelve Trailing Months | 1.51 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.08 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.79 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 46,048,300 |
| Market Capitalization | 796,635,590 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 2/13/2026 |
| Previous Dividend Amount | 0.0100 |
| Current Dividend Amount | 0.0100 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.04 |
| Trailing Annual Dividend Yield | 0.23% |
| Forward Annual Dividend Rate | 0.04 |
| Forward Annual Dividend Yield | 0.23% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.25% |
| 5-Year Average Dividend Yield | 0.23% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | -10.82% |
| Dividend Payout Ratio | 6.35% |
Income Statement |
|
| Quarterly Earnings Growth YOY | -31.60% |
| Annual Earnings Growth | 1.28% |
| Reported EPS 12 Trailing Months | 0.63 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 0.76 |
| Net Income Twelve Trailing Months | 31,168,000 |
| Net Income Past Year | 31,803,000 |
| Net Income Prior Year | 31,400,000 |
| Quarterly Revenue Growth YOY | 7.00% |
| 5-Year Revenue Growth | 1.56% |
| Operating Margin Twelve Trailing Months | 10.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 22,819,000 |
| Total Cash Past Year | 22,847,000 |
| Total Cash Prior Year | 19,157,000 |
| Net Cash Position Most Recent Quarter | -87,436,000 |
| Net Cash Position Past Year | -87,408,000 |
| Long Term Debt Past Year | 110,255,000 |
| Long Term Debt Prior Year | 126,111,000 |
| Total Debt Most Recent Quarter | 110,255,000 |
| Equity to Debt Ratio Past Year | 0.72 |
| Equity to Debt Ratio Most Recent Quarter | 0.71 |
| Total Stockholder Equity Past Year | 279,760,000 |
| Total Stockholder Equity Prior Year | 251,991,000 |
| Total Stockholder Equity Most Recent Quarter | 275,144,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 23,830,710 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.52 |
| Free Cash Flow Past Year | 22,587,000 |
| Free Cash Flow Prior Year | 43,360,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.10 |
| MACD Signal | -0.03 |
| 20-Day Bollinger Lower Band | 15.00 |
| 20-Day Bollinger Middle Band | 17.48 |
| 20-Day Bollinger Upper Band | 19.96 |
| Beta | 1.16 |
| RSI | 60.46 |
| 50-Day SMA | 14.55 |
| 150-Day SMA | 17.36 |
| 200-Day SMA | 18.10 |
System |
|
| Modified | 4/29/2026 7:56:54 PM EST |